Evaluation of the Effect of Reiki on Pain After Spinal Fusion

NCT ID: NCT07062146

Last Updated: 2026-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-09

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study involves patients undergoing lumbar spine surgery (lumbar arthrodesis). It compares the effects of Reiki, an energy-based therapy, with conventional approaches to relieve postoperative pain.

The goal is to determine whether this non-drug method can help reduce pain, limit the use of painkillers, and enhance patient comfort during recovery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chirurgical Intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard treatment (analgesic + kinesitherapy sessions) + Treatment session (Reiki)

treatment with reiki session

Group Type EXPERIMENTAL

reiki

Intervention Type OTHER

Reiki sessions for 30 minutes, on Day-7 before the surgery and on D15 after the surgery

standard treatment (analgesic + kinesitherapy sessions) + Treatment session (Sham)

treatment with sham session

Group Type PLACEBO_COMPARATOR

Sham (No Treatment)

Intervention Type OTHER

Sham sessions for 30 minutes, on D-7 before the surgery and on D15 after the surgery,

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

reiki

Reiki sessions for 30 minutes, on Day-7 before the surgery and on D15 after the surgery

Intervention Type OTHER

Sham (No Treatment)

Sham sessions for 30 minutes, on D-7 before the surgery and on D15 after the surgery,

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \- Subject aged 18 years or older;
* Referred for a lumbar fusion of up to 3 levels.
* Absence of participation in another clinical study.
* Subject affiliated with a social security scheme or beneficiary of such a scheme

Exclusion Criteria

* Neuropathic patient
* Presence of neuropathic pain
* Diagnosis of fibromyalgia
* Received therapeutic touch, polarity therapy, or professional massage therapy in the past four weeks
* Unable to undergo medical follow-up for the study
* Adult subject protected by law, under guardianship or trusteeship
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Clinique Bizet

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Bizet

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bouchra BENKESSOU, PM

Role: CONTACT

0033140693525

georges ABI LAHOUD, Professeur

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bouchra BENKESSOU, PM

Role: primary

0764486016

Georges ABI LAHOUD, Principal Investigator

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A02685-42

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.